LeonaBio, Inc. (LONA) Financials

LONA Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 56.9 million 23.3 million
March 31, 2026 71.6 million 22.3 million
Dec. 31, 2025 92.2 million 64.4 million
Sept. 30, 2025 30.0 million 3.2 million

LONA Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -17.0 million 3.2 million
March 31, 2026 -20.9 million 662000
Dec. 31, 2025 -19.4 million 1.5 million
Sept. 30, 2025 -4.7 million 1.4 million

LONA Net Income

No data available :(

LONA Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 51.1 million 86000 -
March 31, 2026 67.7 million 213000 478000
Dec. 31, 2025 88.3 million 338000 465000
Sept. 30, 2025 25.2 million - 460000

LONA Shares Outstanding

No data available :(

LONA Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 - 12.7 million 6.6 million -
March 31, 2026 - 11.3 million 6.9 million -
Dec. 31, 2025 - 6.7 million 3.8 million -
Sept. 30, 2025 - 2.6 million 4.0 million -

LONA Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 - -
March 31, 2026 - 231000
Dec. 31, 2025 - 68.1 million
Sept. 30, 2025 - 243000

LONA

Price: $3.51

52 week price:
2.87
11.91

Earnings Per Share: -25.19 USD

P/E Ratio: -0.22

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 29.8 million

Links: